Effect of cargo properties on in situ forming implant behavior determined by noninvasive ultrasound imaging
- 19 January 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Drug Delivery and Translational Research
- Vol. 2 (1), 45-55
- https://doi.org/10.1007/s13346-011-0054-y
Abstract
Diagnostic ultrasound has been shown to be an effective method for the noninvasive characterization of in situ forming implant behavior both in vivo and in vitro through the evaluation of the echogenic signal that forms as a consequence of the polymer phase transition from liquid to solid. The kinetics of this phase transition have a direct effect on drug release and can be altered through factors that change the mass transfer events of the solvent and aqueous environment, including properties of the entrapped active agent. This study examined the effect of payload properties on implant phase inversion, swelling, drug release, and polymer degradation. Poly(dl-lactide-co-gylcolide) implants were loaded with either: sodium fluorescein, bovine serum albumin (BSA), doxorubicin (Dox), or 1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI). Fluorescein and Dox were released at near equivalent rates throughout the diffusion phase of release but due to differing drug–matrix interactions, Dox-loaded implants released a lower mass of drug during the degradation phase of release. DiI was not readily released, and due to increased depot hydrophobicity, resulted in significantly lower swelling than the other formulations. The initial echogenicity was higher in Dox-loaded implants than those loaded with fluorescein, but after the initial precipitation, phase inversion and drug release occurred at near equivalent rates for both Dox and fluorescein-loaded implants. Nonlinear mathematical fitting was used to correlate drug release and phase inversion, providing a noninvasive method for evaluating implant release (R 2 > 0.97 for Dox, BSA, and fluorescein; DiI had a correlation coefficient of 0.56).Keywords
This publication has 42 references indexed in Scilit:
- Controlled Delivery of Basal Insulin from Phase-Sensitive Polymeric Systems After Subcutaneous Administration: In Vitro Release, Stability, Biocompatibility, In Vivo Absorption, and Bioactivity of InsulinJournal of Pharmaceutical Sciences, 2011
- Effect of injection site on in situ implant formation and drug release in vivoJournal of Controlled Release, 2010
- Green Preparation Process, Characterization and Antitumor Effects of Doxorubicin–BSA–Dextran NanoparticlesMacromolecular Bioscience, 2010
- Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systemsJournal of Biomedical Materials Research Part A, 2010
- Noninvasive characterization of in situ forming implants using diagnostic ultrasoundJournal of Controlled Release, 2010
- Non-invasive in vivo evaluation of in situ forming PLGA implants by benchtop magnetic resonance imaging (BT-MRI) and EPR spectroscopyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Chemotherapeutic drug transport to brain tumorJournal of Controlled Release, 2009
- Formulation and Evaluation of PLA and PLGA In Situ Implants Containing Secnidazole and/or Doxycycline for Treatment of PeriodontitisAAPS PharmSciTech, 2008
- Controlled delivery of aspirin: Effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systemsInternational Journal of Pharmaceutics, 2008
- Tuning the pKaof Fluorescein to Optimize Binding AssaysAnalytical Chemistry, 2007